Osteoporosis treatment underutilized in older women with hip fracture – Healio

Allentown Morning CallOsteoporosis treatment underutilized in older women with hip fractureHealioFewer than one in five older women receive recommended osteoporosis care in the 6 to 12 months after a hip fracture, according to a nationwide analysis of privately insured, treatment-naive women.Physical therapy helps people afflicted with osteoporosisCoastal PointMinding ‘Dem Bones: Women at Higher Risk for … Continue reading

Shift in Bisphosphonate Use with Revised Osteoporosis Recommendations – Monthly Prescribing Reference (registration)

Shift in Bisphosphonate Use with Revised Osteoporosis RecommendationsMonthly Prescribing Reference (registration)HealthDay News — In response to revised osteoporosis recommendations in 2008, there was a shift in age-related trends in oral bisphosphonate (BP) therapy initiation, according to a study published online February 2 in the Journal of the American … Source:: Osteoporosis Feed       

Osteoporosis treatment gap comes at a high price – The Pharmaceutical Journal

The Pharmaceutical JournalOsteoporosis treatment gap comes at a high priceThe Pharmaceutical JournalSecond, there are few osteoporosis specialists with advanced levels of expertise in managing patients with osteoporosis and bone mineral density (BMD) testing by dual-energy X-ray absorptiometry (DXA) is not universally available or affordable.and more Source:: DXA Feed       

Subcutaneous abaloparatide viable option for postmenopausal women with osteoporosis – Healio

Subcutaneous abaloparatide viable option for postmenopausal women with osteoporosisHealioPostmenopausal women with osteoporosis treated with subcutaneous abaloparatide for 18 months followed by alendronate for 6 months had improved bone mineral density and a reduced risk for fracture, according to findings from the ACTIVExtend study. Source:: Osteoporosis Feed       

Mayo Clinic Proceedings Publishes Positive Results from the ACTIVExtend Clinical Trial of Abaloparatide-SC in … – EconoTimes

Mayo Clinic Proceedings Publishes Positive Results from the ACTIVExtend Clinical Trial of Abaloparatide-SC in …EconoTimes01, 2017 — Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and other endocrine diseases, today announced that positive results …Jane Street Group LLC Buys New Position in … Continue reading

Measuring BTMs could be practical way to identify patient’s adherence to osteoporosis medications – News-Medical.net

News-Medical.netMeasuring BTMs could be practical way to identify patient’s adherence to osteoporosis medicationsNews-Medical.netOral bisphosphonates are common first line treatments for osteoporosis. However, approximately half of patients who begin osteoporosis treatment do not follow their prescribed treatment and/or discontinue treatment within a year. Identifying low …New Position Paper on Screening for Osteoporosis Therapy Adherence PublishedMonthly Prescribing … Continue reading

New Position Paper on Screening for Osteoporosis Therapy Adherence Published – Monthly Prescribing Reference (registration)

New Position Paper on Screening for Osteoporosis Therapy Adherence PublishedMonthly Prescribing Reference (registration)The International Osteoporosis Foundation and European Calcified Tissue Society Working Group proposed a screening strategy measuring certain bone turnover markers in patients who have initiated oral bisphosphonate therapy for postmenopausal …and more Source:: Osteoporosis Feed       

Osteoporosis and Inflammatory Bowel Disease – Healio

HealioOsteoporosis and Inflammatory Bowel DiseaseHealioThe IBD patients most at risk for fracture are postmenopausal women, patients with low BMI and those receiving steroids. Guidelines from several gastroenterologic societies recommend that dual-energy X-ray absorptiometry (DXA) scanning be performed in … Source:: DXA Feed       

Osteoporosis: Expanded Criteria Protects More Patients – https://ryortho.com/ (press release) (subscription)

https://ryortho.com/ (press release) (subscription)Osteoporosis: Expanded Criteria Protects More Patientshttps://ryortho.com/ (press release) (subscription)Ethel Siris, M.D. is the paper’s senior author and chair of the NBHA Clinical Diagnosis Working Group, NBHA Executive Committee member, Madeline C. Stabile Professor of Medicine and Director of the Toni Stabile Osteoporosis Center at Columbia … Source:: Osteoporosis Feed       

Osteoporosis International Publishes Paper Estimating the Prevalence of Osteoporosis in the U.S. Based on the … – PR Newswire (press release)

Osteoporosis International Publishes Paper Estimating the Prevalence of Osteoporosis in the U.S. Based on the …PR Newswire (press release)WASHINGTON, Jan. 10, 2017 /PRNewswire-USNewswire/ — A paper recently published online by Osteoporosis International (available at http://link.springer.com/article/10.1007/s00198-016-3865-3) examined the impact the National Bone Health Alliance’s …and more Source:: Osteoporosis Feed       

Study examines the effects of osteoporosis drugs in children with genetic bone disorders – EurekAlert (press release)

Study examines the effects of osteoporosis drugs in children with genetic bone disordersEurekAlert (press release)Previous case reports in patients with osteogenesis imperfecta (OI) have suggested that treatment with bisphosphonates, which are commonly prescribed for osteoporosis, may be associated with atypical femur fractures. A new retrospective study of 119 … Source:: Osteoporosis Feed       

Could new bone-forming growth factor reverse osteoporosis? – Medical News Today

Medical News TodayCould new bone-forming growth factor reverse osteoporosis?Medical News TodayScientists at the Children’s Medical Center Research Institute at UT Southwestern in Dallas, TX, have uncovered a new bone-forming growth factor that may reverse the bone loss associated with osteoporosis. They say that this discovery has implications … Source:: Osteoporosis Feed       

Advances in Clinical Applications of New Bone Imaging Technology – Medscape

Advances in Clinical Applications of New Bone Imaging TechnologyMedscapeDual-energy X-ray absorptiometry (DXA) is generally a very useful tool for assessing bone mineral density (BMD) and fracture risk. However, observational studies have shown that in certain instances, BMD as measured by DXA systematically over- or … Source:: DXA Feed       

WHO exposes deceptive promotion of industry-supported FRAX osteoporosis screening tool – HealthNewsReview.org

HealthNewsReview.orgWHO exposes deceptive promotion of industry-supported FRAX osteoporosis screening toolHealthNewsReview.orgOne could have thought otherwise given that groups around the world such as Canadian Osteoporosis Society, the American College of Rheumatology and others claim that FRAX was developed by WHO. Its algorithm has been characterized in media … Source:: Osteoporosis Feed       

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis – Dove Medical Press

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosisDove Medical PressAbstract: Hypocalcemia is the most common major adverse event in patients with osteoporosis receiving the bone resorption inhibitor denosumab; however, limited information is available regarding risk factors of hypocalcemia. Therefore, this study aimed … Source:: Osteoporosis Feed       

Experts explore if DXA-derived measurements could predict fracture risk in diabetic patients – News-Medical.net

Experts explore if DXA-derived measurements could predict fracture risk in diabetic patientsNews-Medical.netOsteoporosis is usually diagnosed from bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA). The authors reviewed data on skeletal parameters and techniques readily available from DXA scanning, and considered their utility in … Source:: DXA Feed       

Fracture Liaison Services Showcased at IOF Regionals – https://ryortho.com/ (press release) (subscription)

https://ryortho.com/ (press release) (subscription)Fracture Liaison Services Showcased at IOF Regionalshttps://ryortho.com/ (press release) (subscription)The recent International Osteoporosis Foundation (IOF) Regionals 6th Asia-Pacific Osteoporosis Meeting highlighted the importance of implementing a coordinator-based Fracture Liaison Services (FLS) in clinics and hospitals. According to the November 5, …and more Source:: Osteoporosis Feed       

Bone Health Improved With Menopausal Hormone Therapy – Endocrinology Advisor

Science World ReportBone Health Improved With Menopausal Hormone TherapyEndocrinology AdvisorParticipants’ bone mineral density (BMD) was assessed via dual X-ray absorptiometry (DXA) scans of the lumbar spine, femoral neck, and hip. Trabecular bone scores were assigned based on the results of the DXA scans and were used to assess the quality …Menopausal Hormone Therapy Benefits Bone … Continue reading

ACR Proposes Recommendations for Glucocorticoid-Induced Osteoporosis – MD Magazine

ACR Proposes Recommendations for Glucocorticoid-Induced OsteoporosisMD MagazineUsed for treatment of inflammation in rheumatic diseases, glucocorticoids are known to have negative effects on bone mass, leading to osteoporosis. About 1% of the population uses this class of steroid, according to Buckley, and the most common adverse … Source:: Osteoporosis Feed       

Study Finds Abaloparatide Can Stimulate Bone Formation in Osteoporosis – MD Magazine

Study Finds Abaloparatide Can Stimulate Bone Formation in OsteoporosisMD MagazineNancy Lane, MD discussed her team’s study on abaloparatide, a new preparation of a hormone, and how it can stimulate bone formation. Prior studies had shown, Lane said, that 18 months of treatment in pot menopausal women showed significant increase …and more Source:: Osteoporosis Feed